Linking biosynthetic gene clusters to their metabolites via pathway-targeted molecular networking

Current Topics in Medicinal Chemistry

Volumn 16, Issue 15, 2016, Pages 1705-1716

  Trautman, Eric P ^a   Crawford, Jason M ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biosynthesis; Colibactin; Pathway Targeted Molecular Networking

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; ASPARAGINE DERIVATIVE; BACTERIAL TOXIN; BETA LACTAM ANTIBIOTIC; COLIBACTIN; DOPAMINE TRANSPORTER; GLIOTOXIN; ISOLEUCINE; LINCOMYCIN; NOCARDICIN A; NONRIBOSOMAL PEPTIDE SYNTHETASE; POLYKETIDE SYNTHASE; PRECOLIBACTIN A; SAFRAMYCIN; SEROTONIN 7 RECEPTOR; THIENAMYCIN; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT;

ARTICLE; BIOSYNTHESIS; CYCLIZATION; CYTOTOXICITY; DNA ALKYLATION; DNA BINDING; DNA CROSS LINKING; DNA DAMAGE; GENE CLUSTER; GENE DELETION; GENE SEQUENCE; GENOMICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLITE; METABOLOME; METABOLOMICS; MOLECULAR GENETICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN HYDROLYSIS; TANDEM MASS SPECTROMETRY; BIOLOGY; GENETICS; METABOLISM; MICROFLORA; MULTIGENE FAMILY;

BIOLOGICAL PRODUCTS; BIOSYNTHETIC PATHWAYS; COMPUTATIONAL BIOLOGY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICROBIOTA; MULTIGENE FAMILY;

EID: 84964297944     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026616666151012111046     Document Type: Article

References (117)

1. Newman, D. J.; Cragg, G. M. Natural Products As Sources of New Drugs over the 30 Years from 1981 to2010. J. Nat. Prod. 2012, 75 (3), 311-35.
2. Butler, M. S.; Robertson, A. A.; Cooper, M. A. Natural product and natural product derived drugs in clinical trials. Nat. Prod. Rep., 2014, 31 (11), 1612-61.
3. Li, J. W.-H.; Vederas, J. C. Drug Discovery and Natural Products, End of an Era or an Endless Frontier? Science, 2009, 325, 161-165.
4. Demain, A. L. Importance of microbial natural products and the need to revitalize their discovery. J. Ind. Microbiol. Biotechnol., 2014, 41 (2), 185-201.
5. Challis, G. L. Mining microbial genomes for new natural products and biosynthetic pathways. Microbiology, 2008, 154 (Pt 6), 1555-69.
6. Nett, M.; Ikeda, H.; Moore, B. S. Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat. Prod. Rep., 2009, 26 (11), 1362-84.
7. Brady, S. F.; Simmons, L.; Kim, J. H.; Schmidt, E. W. Metagenomic approaches to natural products from free-living and symbiotic organisms. Nat. Prod. Rep., 2009, 26 (11), 1488-503.
8. Winter, J. M.; Behnken, S.; Hertweck, C. Genomics-inspired discovery of natural products. Curr. Opin. Chem. Biol., 2011, 15 (1), 22-31.
9. Zotchev, S. B.; Sekurova, O. N.; Katz, L. Genome-based bioprospecting of microbes for new therapeutics. Curr. Opin. Biotechnol., 2012, 23 (6), 941-7.
10. Doroghazi, J. R.; Albright, J. C.; Goering, A. W.; Ju, K. S.; Haines, R. R.; Tchalukov, K. A.; Labeda, D. P.; Kelleher, N. L.; Metcalf, W. W. A roadmap for natural product discovery based on largescale genomics and metabolomics. Nat. Chem. Biol., 2014, 10 (11), 963-8.
11. Bachmann, B. O.; Van Lanen, S. G.; Baltz, R. H. Microbial genome mining for accelerated natural products discovery, is a renaissance in the making? J. Ind. Microbiol. Biotechnol., 2014, 41 (2), 175-84.
12. Staley, J. T.; Konopka, A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu. Rev. Microbiol., 1985, 39, 321-46.
13. Kaeberlein, T.; Lewis, K.; Epstein, S. S. Isolating Uncultivable. microorganisms in pure culture in a simulated natural environment. Science, 2002, 296 (5570), 1127-9.
14. Nichols, D.; Cahoon, N.; Trakhtenberg, E. M.; Pham, L.; Mehta, A.; Belanger, A.; Kanigan, T.; Lewis, K.; Epstein, S. S. Use of Ichip for High-Throughput In Situ Cultivation of Uncultivable. Microbial Species. Appl. Environ. Microbiol., 2010, 76 (8), 2445-2450.
15. D'Onofrio, A.; Crawford, J. M.; Stewart, E. J.; Witt, K.; Gavrish, E.; Epstein, S.; Clardy, J.; Lewis, K. Siderophores from neighboring organisms promote the growth of uncultured bacteria. Chem. Biol., 2010, 17 (3), 254-64.
16. Lewis, K.; Epstein, S.; D'Onofrio, A.; Ling, L. L. Uncultured microorganisms as a source of secondary metabolites. J. Antibiot. (Tokyo), 2010, 63 (8), 468-76.
17. Ling, L. L.; Schneider, T.; Peoples, A. J.; Spoering, A. L.; Engels, I.; Conlon, B. P.; Mueller, A.; Schaberle, T. F.; Hughes, D. E.; Epstein, S.; Jones, M.; Lazarides, L.; Steadman, V. A.; Cohen, D. R.; Felix, C. R.; Fetterman, K. A.; Millett, W. P.; Nitti, A. G.; Zullo, A. M.; Chen, C.; Lewis, K. A new antibiotic kills pathogens without detectable resistance. Nature, 2015, 517 (7535), 455-9
18. Scherlach, K.; Hertweck, C. Triggering cryptic natural product biosynthesis in microorganisms. Org. Biomol. Chem., 2009, 7 (9), 1753-60.
19. Williams, R. B.; Henrikson, J. C.; Hoover, A. R.; Lee, A. E.; Cichewicz, R. H. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem., 2008, 6 (11), 1895-7.
20. Gomez-Escribano, J. P.; Bibb, M. J. Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb. Biotechnol., 2011, 4 (2), 207-15.
21. Jensen, P. R.; Chavarria, K. L.; Fenical, W.; Moore, B. S.; Ziemert, N. Challenges and triumphs to genomics-based natural product discovery. J. Ind. Microbiol. Biotechnol., 2014, 41 (2), 203-9.
22. Yang, J. Y.; Sanchez, L. M.; Rath, C. M.; Liu, X.; Boudreau, P. D.; Bruns, N.; Glukhov, E.; Wodtke, A.; de Felicio, R.; Fenner, A.; Wong, W. R.; Linington, R. G.; Zhang, L.; Debonsi, H. M.; Gerwick, W. H.; Dorrestein, P. C. Molecular networking as a dereplication strategy. J. Nat. Prod., 2013, 76 (9), 1686-99.
23. Crawford, J. M.; Clardy, J. Bacterial symbionts and natural products. Chem. Commun. (Camb), 2011, 47 (27), 7559-66.
24. Schmidt, E. W.; Donia, M. S.; McIntosh, J. A.; Fricke, W. F.; Ravel, J. Origin and variation of tunicate secondary metabolites. J. Nat. Prod., 2012, 75 (2), 295-304.
25. Hentschel, U.; Piel, J.; Degnan, S. M.; Taylor, M. W. Genomic insights into the marine sponge microbiome. Nat. Rev. Microbiol., 2012, 10 (9), 641-54.
26. Rath, C. M.; Dorrestein, P. C. The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes. Curr. Opin. Microbiol., 2012, 15 (2), 147-54.
27. Brachmann, A. O.; Bode, H. B. Identification and Bioanalysis of Natural Products from Insect Symbionts and Pathogens. Adv. Biochem. Eng. Biotechnol., 2013, 135, 123-55.
28. Vizcaino, M. I.; Guo, X.; Crawford, J. M. Merging chemical ecology with bacterial genome mining for secondary metabolite discovery. J. Ind. Microbiol. Biotechnol., 2014, 41 (2), 285-99.
29. Lederberg, J. Infectious history. Science, 2000, 288 (5464), 287-93.
30. Donia, M. S.; Cimermancic, P.; Schulze, C. J.; Wieland Brown, L. C.; Martin, J.; Mitreva, M.; Clardy, J.; Linington, R. G.; Fischbach, M. A. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell, 2014, 158 (6), 1402-14.
31. Sharon, G.; Garg, N.; Debelius, J.; Knight, R.; Dorrestein, P. C.; Mazmanian, S. K. Specialized metabolites from the microbiome in health and disease. Cell Metab., 2014, 20 (5), 719-30.
32. Donia, M. S.; Fischbach, M. A. Small molecules from the human microbiota. Science, 2015, 349 (6246), 1254766.
33. Hooper, L. V.; Gordon, J. I. Commensal host-bacterial relationships in the gut. Science, 2001, 292, 1115-8.
34. Round, J. L.; Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol., 2009, 9 (5), 313-23.
35. Cani, P. D.; Delzenne, N. M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des., 2009, 15, 1546-1558.
36. Ley, R. E. Obesity and the human microbiome. Curr. Opin. Gastroenterol., 2010, 26 (1), 5-11.
37. DiBaise, J. K.; Frank, D. N.; Mathur, R. Impact of the Gut Microbiota on the Development of Obesity, Current Concepts. Am. J. Gastroenterol. Suppl., 2012, 1 (1), 22-27.
38. Arthur, J. C.; Perez-Chanona, E.; Muhlbauer, M.; Tomkovich, S.; Uronis, J. M.; Fan, T.-J.; Campbell, B. J.; Abujamel, T.; Dogan, B.; Rogers, A. B.; Rhodes, J. M.; Stintzi, A.; Simpson, K. W.; Hansen, J. J.; Keku, T. O.; Fodor, A. A.; Jobin, C. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota. Science, 2012, 338 (6103), 120-123.
39. Arthur, J. C.; Jobin, C. The complex interplay between inflammation, the microbiota and colorectal cancer. Gut. Microbes, 2013, 4 (3), 253-8.
40. de Vos, W. M.; de Vos, E. A. Role of the intestinal microbiome in health and disease, from correlation to causation. Nutr. Rev., 2012, 70 Suppl 1, S45-56.
41. Human Microbiome Project, C. A framework for human microbiome research. Nature, 2012, 486 (7402), 215-21.
42. Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature, 2012, 486 (7402), 207-14.
43. Nougayrede, J. P.; Homburg, S.; Taieb, F.; Boury, M.; Brzuszkiewicz, E.; Gottschalk, G.; Buchrieser, C.; Hacker, J.; Dobrindt, U.; Oswald, E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science, 2006, 313 (5788), 848-51.
44. Putze, J.; Hennequin, C.; Nougayrede, J. P.; Zhang, W.; Homburg, S.; Karch, H.; Bringer, M. A.; Fayolle, C.; Carniel, E.; Rabsch, W.; Oelschlaeger, T. A.; Oswald, E.; Forestier, C.; Hacker, J.; Dobrindt, U. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect. Immun., 2009, 77 (11), 4696-703.
45. Bondarev, V.; Richter, M.; Romano, S.; Piel, J.; Schwedt, A.; Schulz-Vogt, H. N. The genus Pseudovibrio contains metabolically versatile bacteria adapted for symbiosis. Environ. Microbiol., 2013, 15 (7), 2095-113.
46. Engel, P.; Vizcaino, M. I.; Crawford, J. M. Gut symbionts from distinct hosts exhibit genotoxic activity via divergent colibactin biosynthetic pathways. Appl. Environ. Microbiol., 2014, 81(4), 1502-12.
47. Engel, P.; Bartlett, K. D.; Moran, N. A. The Bacterium Frischella perrara Causes Scab Formation in the Gut of its Honeybee Host. MBio, 2015, 6 (3).
48. Nougayrede, J. P.; Homburg, S.; Taieb, F.; Boury, M.; Brzuszkiewicz, E.; Gottschalk, G.; Buchrieser, C.; Hacker, J.; Dobrindt, U.; Oswald, E. Escherichia coli induces DNA double-stranded breaks in eukaryotic cells. Science, 2006, 313, 848-851.
49. Cuevas-Ramos, G.; Petit, C.; Marcq, I.; Boury, M.; Oswald, E.; Nougayrede, J. P.; Isberg, R. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Nat. Acad. Sci., 2010, 107 (25), 11537-11542.
50. Nowrouzian, F. L.; Oswald, E. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb. Pathog., 2012, 53 (3- 4), 180-2.
51. Arthur, J. C.; Perez-Chanona, E.; Muhlbauer, M.; Tomkovich, S.; Uronis, J. M.; Fan, T. J.; Campbell, B. J.; Abujamel, T.; Dogan, B.; Rogers, A. B.; Rhodes, J. M.; Stintzi, A.; Simpson, K. W.; Hansen, J. J.; Keku, T. O.; Fodor, A. A.; Jobin, C. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota. Science, 2012, 338(6103), 120-3
52. Dalmasso, G.; Cougnoux, A.; Delmas, J.; Darfeuille-Michaud, A.; Bonnet, R. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes, 2014, 5 (5), 675-80.
53. Olier, M.; Marcq, I.; Salvador-Cartier, C.; Secher, T.; Dobrindt, U.; Boury, M.; Bacquie, V.; Penary, M.; Gaultier, E.; Nougayrede, J. P.; Fioramonti, J.; Oswald, E. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes, 2012, 3 (6), 501-9.
54. Brotherton, C. A.; Balskus, E. P. A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity. J. Am. Chem. Soc., 2013, 135 (9), 3359-62.
55. Bian, X.; Fu, J.; Plaza, A.; Herrmann, J.; Pistorius, D.; Stewart, A. F.; Zhang, Y.; Muller, R. In vivo evidence for a prodrug activation mechanism during colibactin maturation. Chembiochem, 2013, 14 (10), 1194-7.
56. Vizcaino, M. I.; Engel, P.; Trautman, E.; Crawford, J. M. Comparative metabolomics and structural characterizations illuminate colibactin pathway-dependent small molecules. J. Am. Chem. Soc., 2014, 136 (26), 9244-7.
57. Vizcaino, M. I.; Crawford, J. M. The colibactin warhead crosslinks DNA. Nat. Chem., 2015, 7 (5), 411-417.
58. Bian, X. Y.; Plaza, A.; Zhang, Y. M.; Muller, R. Two more pieces of the colibactin genotoxin puzzle from Escherichia coli show incorporation of an unusual 1-aminocyclopropanecarboxylic acid moiety. Chem. Sci., 2015, 6 (5), 3154-3160.
59. Brotherton, C. A.; Wilson, M.; Byrd, G.; Balskus, E. P. Isolation of a metabolite from the pks island provides insights into colibactin biosynthesis and activity. Org. Lett., 2015, 17 (6), 1545-8.
60. Brotherton, C. A.; Wilson, M.; Byrd, G.; Balskus, E. P. Correction to Isolation of a Metabolite from the pks Island Provides Insights into Colibactin Biosynthesis and Activity. Org. Lett., 2015, 17 (9), 2294.
61. Li, Z. R.; Li, Y.; Lai, J. Y.; Tang, J.; Wang, B.; Lu, L.; Zhu, G.; Wu, X.; Xu, Y.; Qian, P. Y. Critical intermediates reveal novel biosynthetic events in the enigmatic colibactin pathway. Chembiochem, 2015, 16(12), 1715-9
62. Vizcaino, M. I.; Crawford, J. M. Secondary metabolic pathwaytargeted metabolomics. Meth. Mol. Biol., 2015, In press.
63. Khosla, C. Quo vadis, enzymology? Nat. Chem. Biol., 2015, 11 (7), 438-41.
64. Fischbach, M. A.; Walsh, C. T. Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics, logic, machinery, and mechanisms. Chem. Rev., 2006, 106 (8), 3468-96.
65. Strieker, M.; Tanovic, A.; Marahiel, M. A. Nonribosomal peptide synthetases, structures and dynamics. Curr. Opin. Struct. Biol., 2010, 20 (2), 234-40.
66. Walsh, C. T.; O'Brien, R. V.; Khosla, C. Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds. Angew Chem. Int. Ed. Engl., 2013, 52 (28), 7098-124.
67. Medema, M. H.; Blin, K.; Cimermancic, P.; de Jager, V.; Zakrzewski, P.; Fischbach, M. A.; Weber, T.; Takano, E.; Breitling, R. antiSMASH, rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res., 2011, 39 (Web Server issue), W339-46.
68. Blin, K.; Medema, M. H.; Kazempour, D.; Fischbach, M. A.; Breitling, R.; Takano, E.; Weber, T. antiSMASH 2.0--a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res., 2013, 41 (W1), W204-W212.
69. Blin, K.; Kazempour, D.; Wohlleben, W.; Weber, T. Improved lanthipeptide detection and prediction for antiSMASH. PLoS One, 2014, 9 (2), e89420.
70. Weber, T.; Blin, K.; Duddela, S.; Krug, D.; Kim, H. U.; Bruccoleri, R.; Lee, S. Y.; Fischbach, M. A.; Muller, R.; Wohlleben, W.; Breitling, R.; Takano, E.; Medema, M. H. antiSMASH 3.0-a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res., 2015, 43(W1), W237-43
71. Cimermancic, P.; Medema, M. H.; Claesen, J.; Kurita, K.; Wieland Brown, L. C.; Mavrommatis, K.; Pati, A.; Godfrey, P. A.; Koehrsen, M.; Clardy, J.; Birren, B. W.; Takano, E.; Sali, A.; Linington, R. G.; Fischbach, M. A. Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell, 2014, 158 (2), 412-21.
72. Dantas, G.; Sommer, M. O.; Degnan, P. H.; Goodman, A. L. Experimental approaches for defining functional roles of microbes in the human gut. Annu. Rev. Microbiol., 2013, 67, 459-75.
73. Fang, J.; Dorrestein, P. C. Emerging mass spectrometry techniques for the direct analysis of microbial colonies. Curr. Opin. Microbiol., 2014, 19, 120-9.
74. Watrous, J.; Roach, P.; Alexandrov, T.; Heath, B. S.; Yang, J. Y.; Kersten, R. D.; van der Voort, M.; Pogliano, K.; Gross, H.; Raaijmakers, J. M.; Moore, B. S.; Laskin, J.; Bandeira, N.; Dorrestein, P. C. Mass spectral molecular networking of living microbial colonies. Proc. Natl. Acad. Sci. U. S. A., 2012, 109 (26), E1743-52.
75. Moree, W. J.; Phelan, V. V.; Wu, C. H.; Bandeira, N.; Cornett, D. S.; Duggan, B. M.; Dorrestein, P. C. Interkingdom metabolic transformations captured by microbial imaging mass spectrometry. Proc. Natl. Acad. Sci. U. S. A., 2012, 109 (34), 13811-6.
76. Traxler, M. F.; Watrous, J. D.; Alexandrov, T.; Dorrestein, P. C.; Kolter, R. Interspecies interactions stimulate diversification of the Streptomyces coelicolor secreted metabolome. MBio, 2013, 4 (4).
77. Nguyen, D. D.; Wu, C. H.; Moree, W. J.; Lamsa, A.; Medema, M. H.; Zhao, X.; Gavilan, R. G.; Aparicio, M.; Atencio, L.; Jackson, C.; Ballesteros, J.; Sanchez, J.; Watrous, J. D.; Phelan, V. V.; van de Wiel, C.; Kersten, R. D.; Mehnaz, S.; De Mot, R.; Shank, E. A.; Charusanti, P.; Nagarajan, H.; Duggan, B. M.; Moore, B. S.; Bandeira, N.; Palsson, B. O.; Pogliano, K.; Gutierrez, M.; Dorrestein, P. C. MS/MS networking guided analysis of molecule and gene cluster families. Proc. Natl. Acad. Sci. U. S. A., 2013, 110 (28), E2611-20.
78. Reimer, D.; Bode, H. B. A natural prodrug activation mechanism in the biosynthesis of nonribosomal peptides. Nat. Prod. Rep., 2014, 31 (2), 154-9.
79. Arnison, P. G.; Bibb, M. J.; Bierbaum, G.; Bowers, A. A.; Bugni, T. S.; Bulaj, G.; Camarero, J. A.; Campopiano, D. J.; Challis, G. L.; Clardy, J.; Cotter, P. D.; Craik, D. J.; Dawson, M.; Dittmann, E.; Donadio, S.; Dorrestein, P. C.; Entian, K. D.; Fischbach, M. A.; Garavelli, J. S.; Goransson, U.; Gruber, C. W.; Haft, D. H.; Hemscheidt, T. K.; Hertweck, C.; Hill, C.; Horswill, A. R.; Jaspars, M.; Kelly, W. L.; Klinman, J. P.; Kuipers, O. P.; Link, A. J.; Liu, W.; Marahiel, M. A.; Mitchell, D. A.; Moll, G. N.; Moore, B. S.; Muller, R.; Nair, S. K.; Nes, I. F.; Norris, G. E.; Olivera, B. M.; Onaka, H.; Patchett, M. L.; Piel, J.; Reaney, M. J.; Rebuffat, S.; Ross, R. P.; Sahl, H. G.; Schmidt, E. W.; Selsted, M. E.; Severinov, K.; Shen, B.; Sivonen, K.; Smith, L.; Stein, T.; Sussmuth, R. D.; Tagg, J. R.; Tang, G. L.; Truman, A. W.; Vederas, J. C.; Walsh, C. T.; Walton, J. D.; Wenzel, S. C.; Willey, J. M.; van der Donk, W. A. Ribosomally synthesized and post-translationally modified peptide natural products, overview and recommendations for a universal nomenclature. Nat. Prod. Rep., 2013, 30 (1), 108-60.
80. Hashimoto, M.; Komori, T.; Kamiya, T. Nocardicin A, A New Monocyclic 8-Lactam Antibiotic II. Structure Determination Of Nocardicins A and B. J. Antibiot., 1976, 29, 890-901.
81. Gunsior, M.; Breazeale, S. D.; Lind, A. J.; Ravel, J.; Janc, J. W.; Townsend, C. A. The biosynthetic gene cluster for a monocyclic beta-lactam antibiotic, nocardicin A. Chem. Biol., 2004, 11 (7), 927-38.
82. Davidsen, J. M.; Bartley, D. M.; Townsend, C. A. Non-ribosomal propeptide precursor in nocardicin A biosynthesis predicted from adenylation domain specificity dependent on the MbtH family protein NocI. J. Am. Chem. Soc., 2013, 135 (5), 1749-59.
83. Gaudelli, N. M.; Townsend, C. A. Epimerization and substrate gating by a TE domain in beta-lactam antibiotic biosynthesis. Nat. Chem. Biol., 2014, 10 (4), 251-8.
84. Gaudelli, N. M.; Long, D. H.; Townsend, C. A. beta-Lactam formation by a non-ribosomal peptide synthetase during antibiotic biosynthesis. Nature, 2015, 520 (7547), 383-7.
85. Kevany, B. M.; Rasko, D. A.; Thomas, M. G. Characterization of the complete zwittermicin A biosynthesis gene cluster from Bacillus cereus. Appl. Environ. Microbiol., 2009, 75 (4), 1144-55.
86. Silo-Suh, L. A.; Lethbridge, B. J.; Raffel, S. J.; He, H.; Clardy, J.; Handelsman, J. Biological Activities of Two Fungistatic Antibiotics Produced by Bacillus cereus UW85. Appl. Environ. Microbiol., 1994, 60, 2023-2030.
87. Reimer, D.; Pos, K. M.; Thines, M.; Grun, P.; Bode, H. B. A natural prodrug activation mechanism in nonribosomal peptide synthesis. Nat. Chem. Biol., 2011, 7 (12), 888-90.
88. Dubois, D.; Baron, O.; Cougnoux, A.; Delmas, J.; Pradel, N.; Boury, M.; Bouchon, B.; Bringer, M. A.; Nougayrede, J. P.; Oswald, E.; Bonnet, R. ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J. Biol. Chem., 2011, 286 (41), 35562-70.
89. Cougnoux, A.; Gibold, L.; Robin, F.; Dubois, D.; Pradel, N.; Darfeuille- Michaud, A.; Dalmasso, G.; Delmas, J.; Bonnet, R. Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP. J. Mol. Biol., 2012, 424 (3-4), 203-14.
90. Xu, Y.; Kersten, R. D.; Nam, S. J.; Lu, L.; Al-Suwailem, A. M.; Zheng, H.; Fenical, W.; Dorrestein, P. C.; Moore, B. S.; Qian, P. Y. Bacterial biosynthesis and maturation of the didemnin anti-cancer agents. J. Am. Chem. Soc., 2012, 134 (20), 8625-32.
91. Masschelein, J.; Mattheus, W.; Gao, L. J.; Moons, P.; Van Houdt, R.; Uytterhoeven, B.; Lamberigts, C.; Lescrinier, E.; Rozenski, J.; Herdewijn, P.; Aertsen, A.; Michiels, C.; Lavigne, R. A PKS/NRPS/FAS hybrid gene cluster from Serratia plymuthica RVH1 encoding the biosynthesis of three broad spectrum, zeaminerelated antibiotics. PLoS One, 2013, 8 (1), e54143.
92. Wendenbaum, S.; Demange, P.; Dell, A.; Meyer, J. M.; Abdallah, M. A. The Structure of Pyoverdine Pa, the Siderophore of Pseudomonas- Aeruginosa. Tetrahedron Lett., 1983, 24 (44), 4877-4880.
93. Schalk, I. J. Metal trafficking via siderophores in Gram-negative bacteria, specificities and characteristics of the pyoverdine pathway. J. Inorg. Biochem., 2008, 102 (5-6), 1159-69.
94. Yeterian, E.; Martin, L. W.; Guillon, L.; Journet, L.; Lamont, I. L.; Schalk, I. J. Synthesis of the siderophore pyoverdine in Pseudomonas aeruginosa involves a periplasmic maturation. Amino Acids, 2010, 38 (5), 1447-59.
95. Drake, E. J.; Gulick, A. M. Structural characterization and highthroughput screening of inhibitors of PvdQ, an NTN hydrolase involved in pyoverdine synthesis. ACS Chem. Biol., 2011, 6 (11), 1277-86.
96. Koketsu, K.; Watanabe, K.; Suda, H.; Oguri, H.; Oikawa, H. Reconstruction of the saframycin core scaffold defines dual Pictet- Spengler mechanisms. Nat. Chem. Biol., 2010, 6 (6), 408-10.
97. Itoh, J.; Omoto, S.; Shomura, T.; Nishizawa, N.; Miyado, S.; Yuda, Y.; Shibata, U.; Inouye, S. Amicoumacin-A, A new antibiotic with strong antiinflammatory and antiulcer activity. J. Antibiot., 1981, 34, 611-613.
98. Li, Y.; Xu, Y.; Liu, L.; Han, Z.; Lai, P. Y.; Guo, X.; Zhang, X.; Lin, W.; Qian, P. Y. Five new amicoumacins isolated from a marine- derived bacterium Bacillus subtilis. Mar. Drugs, 2012, 10 (2), 319-28.
99. Li, Y.; Li, Z.; Yamanaka, K.; Xu, Y.; Zhang, W.; Vlamakis, H.; Kolter, R.; Moore, B. S.; Qian, P. Y. Directed natural product biosynthesis gene cluster capture and expression in the model bacterium Bacillus subtilis. Sci. Rep., 2015, 5, 9383.
100. Freeman, M. F.; Moshos, K. A.; Bodner, M. J.; Li, R.; Townsend, C. A. Four enzymes define the incorporation of coenzyme A in thienamycin biosynthesis. Proc. Natl. Acad. Sci. U. S. A., 2008, 105 (32), 11128-33.
101. Bell, M. R.; Johnson, J. R.; Wildi, B. S.; Woodward, R. B. The structure of gliotoxin. J. Am. Chem. Soc., 1958, 80 (4), 1001-1001.
102. Scharf, D. H.; Heinekamp, T.; Remme, N.; Hortschansky, P.; Brakhage, A. A.; Hertweck, C. Biosynthesis and function of gliotoxin in Aspergillus fumigatus. Appl. Microbiol. Biotechnol., 2012, 93 (2), 467-72.
103. Scharf, D. H.; Chankhamjon, P.; Scherlach, K.; Heinekamp, T.; Willing, K.; Brakhage, A. A.; Hertweck, C. Epidithiodiketopiperazine Biosynthesis, A Four-Enzyme Cascade Converts Glutathione Conjugates into Transannular Disulfide Bridges. Angew. Chem. Int. Ed., 2013, 52 (42), 11092-11095.
104. Zhao, Q.; Wang, M.; Xu, D.; Zhang, Q.; Liu, W. Metabolic coupling of two small-molecule thiols programs the biosynthesis of lincomycin A. Nature, 2015, 518 (7537), 115-9.
105. Dobrindt, U.; Hochhut, B.; Hentschel, U.; Hacker, J. Genomic islands in pathogenic and environmental microorganisms. Nat. Rev. Microbiol., 2004, 2 (5), 414-24.
106. Guo, X.; Crawford, J. M. An atypical orphan carbohydrate-NRPS genomic island encodes a novel lytic transglycosylase. Chem. Biol., 2014, 21 (10), 1271-7.
107. Adams, D. O.; Yang, S. F. Ethylene Biosynthesis - Identification of 1-Aminocyclopropane-1-Carboxylic Acid as an Intermediate in the Conversion of Methionine to Ethylene. Proc. Natl. Acad. Sci. U. S. A., 1979, 76 (1), 170-174.
108. Thibodeaux, C. J.; Chang, W. C.; Liu, H. W. Enzymatic chemistry of cyclopropane, epoxide, and aziridine biosynthesis. Chem. Rev., 2012, 112 (3), 1681-709.
109. Vaillancourt, F. H.; Yeh, E.; Vosburg, D. A.; O'Connor, S. E.; Walsh, C. T. Cryptic chlorination by a non-haem iron enzyme during cyclopropyl amino acid biosynthesis. Nature, 2005, 436 (7054), 1191-4.
110. Zhang, H.; Kakeya, H.; Osada, H. Biosynthesis of 1- aminoeyclopropane-l-carboxylic acid moiety on cytotrienin A in Streptomyces sp. Tetrahedron Lett., 1998, 39, 6947-6948.
111. Brachmann, A. O.; Garcie, C.; Wu, V.; Martin, P.; Ueoka, R.; Oswald, E.; Piel, J. Colibactin biosynthesis and biological activity depend on the rare aminomalonyl polyketide precursor. Chem. Commun. (Camb), 2015, 51 (66), 13138-41.
112. Chan, Y. A.; Boyne, M. T. 2nd; Podevels, A. M.; Klimowicz, A. K.; Handelsman, J.; Kelleher, N. L.; Thomas, M. G. Hydroxymalonyl- acyl carrier protein (ACP) and aminomalonyl-ACP are two additional type I polyketide synthase extender units. Proc. Natl. Acad. Sci. U. S. A., 2006, 103 (39), 14349-54.
113. Holmes, T. C.; May, A. E.; Zaleta-Rivera, K.; Ruby, J. G.; Skewes- Cox, P.; Fischbach, M. A.; DeRisi, J. L.; Iwatsuki, M.; Omura, S.; Khosla, C. Molecular insights into the biosynthesis of guadinomine, a type III secretion system inhibitor. J. Am. Chem. Soc., 2012, 134 (42), 17797-806.
114. Park, H. B.; Crawford, J. M. Lumiquinone A, an alpha- Aminomalonate-Derived Aminobenzoquinone from Photorhabdus luminescens. J. Nat. Prod., 2015, 78 (6), 1437-41.
115. Fu, D.; Calvo, J. A.; Samson, L. D. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer, 2012, 12 (2), 104-20.
116. Takita, T.; Muraoka, Y.; Yoshioka, T.; Fujii, A.; Maeda, K.; Umezawa, H. Chemistry of Bleomycin.9. Structures of Bleomycin and Phleomycin. J. Antibiot., 1972, 25 (12), 755-758.
117. Stubbe, J.; Kozarich, J. W. Mechanisms of bleomycin-induced DNA degradation. Chem. Rev., 1987, 87, 1107-1136.